Books on the topic 'Patented drugs'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 books for your research on the topic 'Patented drugs.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse books on a wide variety of disciplines and organise your bibliography correctly.
Corvari, Ronald. Trends in patented drug prices. Patented Medicine Prices Review Board, 1998.
Find full textCorvari, Ronald. Verification of foreign patented drug prices. Patented Medicine Prices Review Board, 1998.
Find full textPatented Medicine Prices Review Board Canada. The impact of federal regulation of patented drug prices. The Board, 1997.
Find full textMilligan, Eric A. A history of the Patented Medicines Prices Review Board: The early years. Canadian Centre for Management Development, 1991.
Find full textNew York (State). Legislature. Senate. Committee on Corporations, Authorities, and Commissions. In the matter of high cost of patented pharmaceutical prescription medications: Legislative Office Building, Hearing Room B, Albany, New York, May 31, 2000, 10:10 a.m. to 3:25 p.m., Wednesday. Candyco Transcription Service, Inc., 2000.
Find full textOffice, General Accounting. Prescription drug prices: Analysis of Canada's Patented Medicine Prices Review Board : report to the chairman, Special Committee on Aging, U.S. Senate. The Office, 1993.
Find full textNetwork, Canadian HIV/AIDS Legal. Controlling drug costs for people living with HIV/AIDS: Federal regulation of pharmaceutical prices in Canada. Canadian HIV/Aids Legal Network = Réseau juridique canadien VIH/sida, 2004.
Find full textOffice, General Accounting. Prescription drug prices: Official index overstates producer price inflation : report to the Chairman, Special Committee on Aging, U.S. Senate. The Office, 1995.
Find full textCanada. Patented Medicine Prices Review Board. Annual report 2007. Patented Medicine Prices Review Board, 2008.
Find full textHouse, United States Congress. A bill to amend title 35, United States Code, to provide for compulsory licensing of certain patented inventions relating to health. [United States Government Printing Office], 1999.
Find full textHarnisch, Sandy. Die Zwangslizenz im südafrikanischen und deutschen Patentrecht: Ein Rechtsvergleich unter besonderer Berücksichtigung der Arzneimittelerfindungen. BWV, Berliner Wiss.-Verl., 2006.
Find full textSantini, Picarelli Márcia Flávia, Aranha Márcio Iorio, and Barbosa A. L. Figueira, eds. Política de patentes em saúde humana. Editora Atlas, 2001.
Find full textZárate, José Manuel Alvarez. Los monopolios patentarios y sus procedimientos judiciales. Biblioteca Jurídica Diké, 2002.
Find full textShachar, Josh Yehoshua. Frontiers in drug delivery: Pharmaco-kinesis collected patents. Pharmaco-Kinesis Corporation, 2010.
Find full textUnited, States Congress House Committee on the Judiciary Subcommittee on Courts Civil Liberties and the Administration of Justice. Lopid Patent Term Restoration and Fairness Act of 1987: Hearing before the Subcommittee on Courts, Civil Liberties, and the Administration of Justice of the Committee on the Judiciary, House of Representatives, One Hundredth Congress, first session, October 8, 1987. U.S. G.P.O., 1988.
Find full textVoet, Martin A. The generic challenge: Understanding patents, FDA & pharmaceutical life-cycle management. 2nd ed. BrownWalker Press, 2008.
Find full textSánchez, Paloma Pérez. Industria farmaceutica y patentes. Registro de la Propiedad Industrial, Ministerio de Industria y Energia, 1990.
Find full textZuccherino, Daniel R. Derecho de patentes, aislamiento o armonización: La patentabilidad de los productos farmacéuticos. Ad-Hoc, 1994.
Find full textIndian Institute of Management, Ahmedebad., ed. Value addition to local Kani tribal knowledge: Patenting, licensing, and benefit-sharing. Indian Institute of Management, 2002.
Find full textCanada. Commission of Inquiry on the Pharmaceutical Industry., ed. Issues in patent policy with respect to the pharmaceutical industry. Minister of Supply and Services, 1986.
Find full textMaria Stela Pompeu Brasil Frota. Proteção de patentes de produtos farmacêuticos: O caso brasileiro. Fundação Alexandre de Gusmão, Instituto de Pesquisa de Relações Internacionais, 1993.
Find full textEnvironment, United States Congress House Committee on Energy and Commerce Subcommittee on Health and the. Drug issues. U.S. G.P.O., 1988.
Find full textProperty, United States Congress House Committee on the Judiciary Subcommittee on Courts and Intellectual. Patent Fairness Act of 1999: Hearing before the Subcommittee on Courts and Intellectual Property of the Committee on the Judiciary, House of Representatives, One Hundred Sixth Congress, first session, on H.R. 1598, July 1, 1999. U.S. G.P.O., 2000.
Find full textEnvironment, United States Congress House Committee on Energy and Commerce Subcommittee on Health and the. Generic animal drugs: Hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, second session, on H.R. 5069 ... July 29, 1986. U.S. G.P.O., 1987.
Find full textEnvironment, United States Congress House Committee on Energy and Commerce Subcommittee on Health and the. Generic animal drugs: Hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, second session, on H.R. 5069 ... July 29, 1986. U.S. G.P.O., 1987.
Find full textUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment. Generic animal drugs: Hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, second session, on H.R. 5069 ... July 29, 1986. U.S. G.P.O., 1987.
Find full textBeers, Donald O. Generic drugs: A guide to FDA approval requirements. Prentice Hall Law & Business, 1988.
Find full textBeers, Donald O. Generic drugs: A guide to FDA approval requirements. 2nd ed. Prentice Hall Law & Business, 1989.
Find full textUnited, States Congress Senate Committee on the Judiciary Subcommittee on Patents Copyrights and Trademarks. Agricultural Patent Reform Act: Hearing before the Subcommittee on Patents, Copyrights, and Trademarks of the Committee on the Judiciary, Unitd States Senate, Ninety-ninth Congress, first session, on S. 1093 ... September 10, 1985. U.S. G.P.O., 1986.
Find full textWisātsakun, Wīrabūn. Thāngdœ̄n khō̜ng khon lek lek thī cha sū kap rư̄ang yai: Botrīan kānphœ̄kthō̜n sitthibat yā DīDīʻAi. Mūnnithi Sathāranasuk kap Kānphatthanā, 2004.
Find full textUnited States. Congress. House. Committee on the Judiciary. Agricultural Patent Reform Act: Report (to accompany H.R. 5536) (including cost estimate of the Congressional Budget Office). U.S. G.P.O., 1986.
Find full textGómez, Marta Ortega. Patentes farmacéuticas y países en desarrollo. Difusión Jurídica, Economist & Jurist, 2011.
Find full textUnited States. Congress. House. Committee on the Judiciary. Subcommittee on Courts, Civil Liberties, and the Administration of Justice. Agricultural patent term restoration: Hearing before the Subcommittee on Courts, Civil Liberties, and the Administration of Justice of the Committee on the Judiciary, House of Representatives, Ninety-ninth Congress, second sesssion, on H.R. 3897 ... July 17, 1986. U.S. G.P.O., 1986.
Find full textGarcía-Miján, Manuel Lobato. El nuevo marco legal de las patentes químicas y farmacéuticas. Editorial Civitas, 1994.
Find full textBarr, David K., and Daniel L. Reisner. Developments in pharmaceutical and biotech patent law 2013. Practising Law Institute, 2013.
Find full textGrangeiro, Alexandre. Propriedade intelectual, patentes & acesso universal a medicamentos. Grupo de Incentivo à Vida, 2006.
Find full textO, Beers Donald, ed. Generic and innovator drugs: A guide to FDA approval requirements. 3rd ed. Prentice Hall Law & Business, 1992.
Find full textD, Korchagin A., Federalʹnai͡a︡ t͡s︡elevai͡a︡ programma "Kulʹtura Rossii." Podprogramma "Podderzhka poligrafii i knigoizdanii͡a︡ Rossii.", and Russia (Federation), eds. Kommentariĭ k Patentnomu zakonu Rossiĭskoĭ Federat͡s︡ii. Izd-vo "Kompanii͡a︡ Dimitreĭd Grafik Grupp", 2004.
Find full textAhn, Hyewon. Patentability of chemical selection inventions: The Olanzapine and Escitalopram decisions. Nomos, 2011.
Find full textGenovesi, Luis Mariano. Patentes y medicamentos: Un tema para debatir. Fundación Argentina y el Mundo, 1995.
Find full textKotowitz, Y. Issues in patent policy with respect to the pharmaceutical industry. Commission of Inquiry on the Pharmaceutical Industry; Supply and Services Canada, 1986.
Find full textResources, United States Congress Senate Committee on Labor and Human. Animal Drug Amendments and Patent Term Restoration Act of 1986: Hearing before the Committee on Labor and Human Resources, United States Senate, Ninety-ninth Congress, second session, on S. 2407 ... July 18, 1986. U.S. G.P.O., 1986.
Find full textResources, United States Congress Senate Committee on Labor and Human. Animal Drug Amendments and Patent Term Restoration Act of 1986: Report together with minority views (to accompany S. 2407). U.S. G.P.O., 1986.
Find full textResources, United States Congress Senate Committee on Labor and Human. Animal Drug Amendments and Patent Term Restoration Act of 1986: Hearing before the Committee on Labor and Human Resources, United States Senate, Ninety-ninth Congress, second session, on S. 2407 ... July 18, 1986. U.S. G.P.O., 1986.
Find full text